Immunohistochemical examination of the tissue from 29 patients with prostate cancer and 33 patients with breast cancer, demonstrated in 7 there was high NDRG1 levels in normal prostate and breast epithelium, whereas a significant down-regulation was observed in high-grade cancers (7). Here, NDRG1 is linked to prostate carcinoma.